Prenetics Global Ltd
PRENW0.033USD
+0.000+0.31%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Prenetics Global Ltd Company
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Company Info
Ticker SymbolPRENW
Company namePrenetics Global Ltd
IPO dateJul 06, 2021
CEOMr. Joel Neoh
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
AddressUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
City
Stock exchangeNASDAQ Capital Market Consolidated
CountryHong Kong
Postal code- -
Phone85222109588
Websitehttps://ir.prenetics.com/
Ticker SymbolPRENW
IPO dateJul 06, 2021
CEOMr. Joel Neoh
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Ms. Samantha Kwok
Ms. Samantha Kwok
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
30
3.30M
0.00%
-1.79M
2025Q1
31
3.30M
0.00%
-1.97M
2024Q4
34
4.00M
0.00%
-742.40K
2024Q3
37
3.17M
0.00%
-3.22M
2024Q2
39
4.52M
0.00%
-1.61M
2024Q1
39
4.73M
0.00%
-1.56M
2023Q4
39
5.08M
0.00%
-1.26M
2023Q3
38
5.18M
0.00%
-1.17M
2023Q2
36
5.20M
0.00%
-1.29M
2023Q1
36
5.53M
0.00%
-1.11M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
LMR Partners LLP
1.30M
0%
--
--
Mar 31, 2025
Aspex Management (HK) Limited
1.17M
0%
--
--
Mar 31, 2025
Citadel Advisors LLC
12.77K
0%
-301.52K
-95.94%
Mar 31, 2025
Calamos Advisors LLC
200.00K
0%
--
--
Mar 31, 2025
Walleye Capital LLC
160.29K
0%
-35.53K
-18.15%
Mar 31, 2025
D. E. Shaw & Co., L.P.
104.52K
0%
--
--
Mar 31, 2025
Jane Street Capital, L.L.C.
82.65K
0%
--
--
Mar 31, 2025
Peak6 Capital Management LLC
66.67K
0%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
